Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 48

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
6021038
  • C Sequence analysis of the entire coding region

Amyotrophic lateral sclerosis, susceptibility to

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic lateral sclerosis type 1

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis (ALS)

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis Exome Panel

Northwest Clinical Genomics Laboratory University of Washington
United States
1624
  • C Sequence analysis of the entire coding region

SOD1, FUS, TARDBP, ANG, C9orf72. NextGeneDx.Complete sequencing by NGS

Instituto de Medicina Genomica
Spain
35
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Sequencing Panel

PreventionGenetics
United States
1621
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15411578
  • C Sequence analysis of the entire coding region

TARDBP. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

ANG. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

SOD1. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

C9orf72. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MitoMet®Plus aCGH Analysis

Baylor Miraca Genetics Laboratories
United States
845637
  • D Deletion/duplication analysis

Amyotrophic Lateral Sclerosis / Motor Neuron Disease via the SOD1 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

nucSEEK® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Superoxide dismutase 1 (SOD1) gene sequencing test

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
11
  • C Sequence analysis of the entire coding region

AMYOTROPHIC LATERAL SCLEROSIS A.D. & A.R.

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1111
  • C Sequence analysis of the entire coding region

Amyotrophic lateral sclerosis 1 (sequence analysis of SOD1 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Single gene testing SOD1

CeGaT GmbH
Germany
11
  • C Sequence analysis of the entire coding region

Amyotrophic lateral sclerosis, susceptibility to (sequence analysis of NEFH gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 48

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.